Histamine

The dosage of Histamine Phosphate is highly specialized and depends entirely on the diagnostic procedure being performed.

• Skin Prick Testing (Allergy Control): Healthcare providers typically use a single drop of a 1 mg/mL or 10 mg/mL solution. A lancet is used to prick the skin through the drop. The result is read exactly 15 minutes later.
• Intradermal Testing: If a skin prick test is inconclusive, a doctor may inject a much more dilute solution (usually 0.01 to 0.1 mg/mL) into the top layer of the skin. The volume is typically very small, around 0.02 mL, to create a tiny bleb.
• Gastric Secretion Test: Historically, a dose of 0.01 mg to 0.04 mg per kilogram of body weight was administered subcutaneously. This is rarely done today due to the availability of pentagastrin and other safer alternatives.
• Bronchial Challenge: Doses start extremely low (e.g., 0.03 mg/mL) and are doubled at set intervals until a 20% drop in lung function (FEV1) is observed or the maximum dose is reached.

Histamine Phosphate is used in children for allergy testing, but the procedure requires even greater care.

• Allergy Testing (Skin Prick): The procedure is similar to adults, but healthcare providers often limit the number of tests performed at once to minimize discomfort and the risk of systemic absorption.
• Intradermal Testing: Generally avoided in very young children unless absolutely necessary, as it is more painful and carries a higher risk of systemic reactions.
• Safety Note: Histamine Phosphate has not been extensively studied for therapeutic use in children; its use is strictly limited to diagnostic contexts under the supervision of a pediatric allergist.

Renal Impairment

Since histamine metabolites are cleared through the kidneys, patients with severe renal failure may experience a slightly prolonged systemic effect if large doses are used. However, for standard skin testing, no specific dosage adjustment is usually required.

Hepatic Impairment

The liver plays a role in the methylation of histamine. While no formal guidelines exist for dosage adjustment in liver disease, healthcare providers should exercise caution in patients with advanced cirrhosis if systemic administration is planned.

Elderly Patients

Elderly patients may be more sensitive to the cardiovascular effects of histamine, such as rapid heart rate (tachycardia) or changes in blood pressure. Lower concentrations may be used initially during provocative testing to ensure safety.

Histamine Phosphate is never self-administered. It is always given by a trained medical professional.

1. 1Preparation: The skin (usually the forearm or back) is cleaned with alcohol and allowed to dry.
2. 2Application: For skin prick testing, a drop is placed on the skin, and a sterile device is used to gently puncture the epidermis.
3. 3Observation: The patient must remain in the clinic for at least 20 to 30 minutes after administration. The healthcare provider will measure the 'wheal' (the raised bump) and the 'flare' (the surrounding redness) using a millimeter ruler.
4. 4Storage: Vials should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F) and protected from light. If the solution becomes discolored or contains particles, it must be discarded.

As Histamine Phosphate is used for one-time diagnostic procedures, a 'missed dose' is not applicable in the traditional sense. If a diagnostic test is interrupted or a dose is not administered correctly, the healthcare provider will determine when it is safe to repeat the procedure, usually after the skin has returned to its baseline state (often 24 to 48 hours).

An overdose of histamine is a medical emergency and can lead to systemic 'histamine poisoning.'

• Signs of Overdose: Intense flushing, severe headache, dizziness, rapid heartbeat (tachycardia), sudden drop in blood pressure (hypotension), abdominal cramps, vomiting, and difficulty breathing (bronchospasm).
• Emergency Measures: The immediate treatment for a systemic histamine reaction is the administration of epinephrine (adrenaline). Healthcare providers will also use antihistamines (H1 and H2 blockers) and intravenous fluids to stabilize blood pressure. Oxygen may be administered if the patient is experiencing respiratory distress.

> Important: Follow your healthcare provider's instructions. Do not attempt to use any histamine-containing products without direct medical supervision.

Because Histamine Phosphate is designed to cause a reaction, 'side effects' at the site of administration are actually the intended result in most diagnostic cases. However, they can still be uncomfortable.

• Local Pruritus (Itching): Almost all patients will experience intense itching at the site of the skin test. This typically peaks at 15 minutes and fades within an hour.
• Wheal and Flare: A raised, pale bump (wheal) surrounded by a red area (flare) is expected. This can sometimes be large (20-30mm) and may feel warm to the touch.
• Local Tenderness: The area may remain slightly sensitive for several hours after the test.

These effects occur when a small amount of histamine enters the general circulation or when a patient is particularly sensitive.

• Flushing: A sudden feeling of warmth and redness in the face, neck, or upper chest.
• Headache: A brief, throbbing headache (often called a 'histamine headache') caused by the dilation of blood vessels in the brain.
• Dizziness: A mild feeling of lightheadedness, usually lasting only a few minutes.
• Nausea: Some patients may feel a brief upset stomach, especially if the drug was administered for a gastric function test.

• Tachycardia: A noticeable racing or pounding heart.
• Hypotension: A temporary drop in blood pressure that may cause the patient to feel faint.
• Urticaria (Hives): Hives appearing in areas away from the injection site, indicating a mild systemic allergic-like reaction.
• Dyspnea: Mild shortness of breath or a feeling of chest tightness.

> Warning: Stop the procedure and alert medical staff immediately if you experience any of the following during or after a histamine test.

• Anaphylaxis: This is a severe, life-threatening systemic reaction. Symptoms include a sudden feeling of doom, swelling of the lips/tongue/throat, extreme difficulty breathing, and fainting.
• Severe Bronchospasm: Intense wheezing or inability to catch one's breath, particularly in patients with a history of asthma.
• Cardiac Arrhythmia: Irregular heartbeats or severe chest pain.
• Seizures: Though extremely rare, high systemic levels of histamine can lower the seizure threshold in susceptible individuals.
• Profuse Vomiting or Diarrhea: Indicating severe systemic involvement and potential shock.

Histamine Phosphate is not used for long-term therapy, so chronic side effects are not well-documented. However, repeated skin testing in the same area can lead to:

• Skin Sensitization: Very rarely, the skin may become hyper-reactive to any touch or minor irritation in the area where testing was performed.
• Pigmentation Changes: In rare cases, a small area of hyperpigmentation (darkening of the skin) may remain at the site of a very strong wheal and flare reaction for several weeks.

There are currently no formal FDA Black Box Warnings for Histamine Phosphate when used as a diagnostic agent. However, the product labeling carries significant 'Precautions' and 'Warnings' regarding the risk of severe bronchial constriction in asthmatic patients and the necessity of having emergency resuscitation equipment available during use.

Report any unusual symptoms or persistent skin changes to your healthcare provider. If you feel unwell after leaving the clinic, contact your doctor or seek emergency care immediately.

Histamine Phosphate is a potent bioactive substance. Its use is strictly diagnostic and must be confined to clinical environments where patients can be monitored. The primary safety concern is the transition from a localized skin reaction to a systemic reaction. Patients must be informed that the test involves the intentional induction of a localized allergic-type response.

No FDA black box warnings for Histamine Phosphate. However, it is considered a high-alert medication in many clinical settings due to its potential to induce rapid cardiovascular and respiratory changes.

• Anaphylaxis Risk: While rare during skin prick testing, systemic absorption can lead to anaphylaxis. This risk is higher with intradermal testing or gastric function testing. Facilities must have an 'anaphylaxis kit' (including epinephrine, oxygen, and IV fluids) ready at all times.
• Asthma and Respiratory Disease: Histamine is a potent bronchoconstrictor. In patients with unstable asthma or significantly reduced lung function, even a small amount of histamine can trigger a severe asthma attack. Healthcare providers will often perform a baseline lung function test (spirometry) before using histamine.
• Cardiovascular Disease: Histamine causes vasodilation and can increase heart rate. Patients with a recent heart attack (myocardial infarction), unstable angina, or severe high blood pressure (hypertension) are at increased risk for cardiac complications during testing.
• Peptic Ulcer Disease: Because histamine stimulates gastric acid secretion, it can exacerbate existing stomach ulcers or cause bleeding in patients with a history of severe acid-related disorders.

During and after the administration of Histamine Phosphate, the following monitoring is typically required:

• Visual Observation: A nurse or doctor must observe the patient for signs of systemic flushing, hives, or respiratory distress for at least 20 minutes.
• Vital Signs: In systemic testing (like gastric function), blood pressure and heart rate should be monitored at regular intervals.
• Lung Auscultation: If a patient reports chest tightness, the doctor will listen to the lungs for wheezing.
• Measurement of Reaction: The diameter of the wheal and flare must be accurately recorded in the medical record to provide a baseline for other tests.

Most patients can drive themselves home after a skin prick test, provided they have stayed for the observation period and feel completely normal. However, if a patient experiences dizziness, a headache, or received systemic treatment for a reaction, they should not drive or operate heavy machinery until all symptoms have completely resolved.

Alcohol can act as a vasodilator and may enhance the effects of histamine. Patients are generally advised to avoid alcohol for 24 hours before and after diagnostic histamine testing to ensure the accuracy of the results and minimize the risk of flushing or headaches.

As this is a single-use diagnostic, 'discontinuation' refers to stopping a procedure in progress. If a patient shows any sign of a systemic reaction, the test is immediately stopped, the site is cleaned, and treatment is administered. There is no withdrawal syndrome associated with Histamine Phosphate.

> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Histamine testing.

There are few absolute contraindications for drug combinations because histamine is used diagnostically, but certain drugs make the test dangerous or useless:

• Non-Selective Beta-Blockers (e.g., Propranolol): These are highly problematic. If a patient on a beta-blocker has a severe reaction to histamine, the beta-blocker may prevent epinephrine (the life-saving treatment) from working effectively. This can make a systemic reaction much more difficult to treat.
• MAO Isocarboxazid, Phenelzine): Monoamine oxidase inhibitors interfere with the breakdown of histamine. This can lead to exaggerated and prolonged responses, including dangerous spikes in blood pressure or severe headaches.

• Tricyclic Antidepressants (TCAs): Drugs like Amitriptyline have potent antihistamine properties. They can completely suppress the skin's reaction to histamine, leading to a 'false negative' control and invalidating the entire allergy test.
• H1-Antihistamines: Common medications like Cetirizine (Zyrtec), Loratadine (Claritin), and Diphenhydramine (Benadryl) must be stopped several days before testing. If not stopped, they will block the H1 receptors, and the histamine control will not work.
• H2-Antihistamines: Drugs like Famotidine (Pepcid) can interfere with gastric function testing and may slightly dampen the skin's flare response.

• Corticosteroids: While short-term systemic steroids (like Prednisone) have a minimal effect on the immediate skin prick reaction, long-term use or high-dose topical steroids at the test site can thin the skin and alter the inflammatory response.
• Phenothiazines: Some antipsychotic medications have antihistamine effects and can interfere with the diagnostic accuracy of the test.

• High-Histamine Foods: Consuming foods very high in histamine (aged cheeses, fermented meats, red wine, sauerkraut) immediately before a test might theoretically increase the baseline 'histamine load,' though this is rarely clinically significant for skin testing.
• Caffeine: May slightly increase heart rate, which could be confused with a systemic reaction to histamine.

• Quercetin: This supplement is often used as a natural antihistamine and may dampen the response to Histamine Phosphate.
• St. John's Wort: May interact with the metabolism of various drugs used during the procedure or the management of reactions.

Histamine Phosphate administration is intended to create a 'lab result' (the wheal and flare). However, it does not typically interfere with standard blood work (like CBC or metabolic panels) unless a severe systemic reaction occurs, which might cause a temporary rise in white blood cell counts or blood glucose due to stress.

For each major interaction, the mechanism is usually pharmacodynamic (blocking the receptor the drug needs to hit) or metabolic (slowing the breakdown of the drug). The clinical consequence is usually a false negative test result or an increased risk of toxicity.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for allergies, depression, or blood pressure.

Histamine Phosphate must NEVER be used in the following circumstances:

1. 1Known Hypersensitivity to Histamine: If a patient has previously had a severe systemic reaction to Histamine Phosphate, they must not be re-exposed.
2. 2Severe, Uncontrolled Asthma: Because histamine is a potent trigger for bronchospasm, using it in a patient who is already struggling to breathe or who has a very low FEV1 (lung function) is extremely dangerous.
3. 3Recent Myocardial Infarction (Heart Attack): Within the last 3-6 months. The cardiovascular stress of a potential histamine reaction could trigger another cardiac event.
4. 4Severe Hypotension (Low Blood Pressure): Since histamine causes vasodilation and further lowers blood pressure, it can lead to circulatory collapse in patients who are already hypotensive.
5. 5Pheochromocytoma: In patients with this adrenal tumor, histamine can cause a massive release of catecholamines (adrenaline), leading to a life-threatening hypertensive crisis.

In these cases, the healthcare provider must weigh the diagnostic benefit against the potential risks:

• Pregnancy: Use only if the diagnostic information is essential and cannot wait until after delivery.
• Active Peptic Ulcer Disease: Risk of stimulating excessive acid and causing a bleed.
• Compensated Cardiovascular Disease: Patients with stable angina or controlled hypertension require extra monitoring.
• Vasomotor Instability: Patients prone to fainting or significant fluctuations in vascular tone.

There is no significant cross-sensitivity between histamine and other common drugs, as histamine is a naturally occurring molecule in the body. However, patients who are highly sensitive to sulfites should be checked, as some older formulations of histamine or related diagnostic agents may have contained sulfite preservatives.

> Important: Your healthcare provider will evaluate your complete medical history, especially your heart and lung health, before prescribing Histamine.

Histamine Phosphate is classified as FDA Pregnancy Category C. This means there are no adequate, well-controlled studies in pregnant women.

• Risks: The primary concern during pregnancy is the risk of a systemic reaction (anaphylaxis), which could cause maternal hypotension and subsequent fetal hypoxia (lack of oxygen to the baby).
• Clinical Use: Allergy skin testing is generally postponed until after delivery unless the allergy being tested for is life-threatening and requires immediate diagnosis for management during pregnancy.

It is not known whether exogenous Histamine Phosphate is excreted in human milk. However, because the half-life of histamine is extremely short (minutes), it is highly unlikely that any significant amount would reach the infant through breastfeeding.

• Recommendation: Most healthcare providers suggest that breastfeeding can be resumed shortly after a skin test, once any local or mild systemic symptoms in the mother have resolved.

Histamine Phosphate is widely used in children as a positive control for allergy testing.

• Approved Use: It is safe for use in infants and children when performed by a specialist.
• Special Considerations: Children have thinner skin and may show larger reactions than adults. They are also more likely to be distressed by the itching. Healthcare providers often use more dilute solutions or fewer test sites in very young children.
• Growth Effects: There are no known effects on growth or development from diagnostic use.

Patients over the age of 65 may have different responses to Histamine Phosphate.

• Skin Reactivity: Skin becomes less reactive with age (atrophy of mast cells and reduced vascular response), which may result in smaller wheal and flare sizes. This must be accounted for when interpreting the test.
• Cardiovascular Sensitivity: Older adults are at higher risk for tachycardia or lightheadedness if systemic absorption occurs.
• Renal Function: Reduced kidney function in the elderly may slightly slow the clearance of histamine metabolites.

While the kidneys are the primary route for excreting histamine metabolites, no specific dosage adjustments are required for standard skin testing. In the rare case of systemic diagnostic testing, patients with a GFR < 30 mL/min should be monitored more closely for prolonged flushing or headache.

In patients with severe liver failure (Child-Pugh Class C), the methylation of histamine may be impaired. These patients should be monitored for signs of increased histamine sensitivity, although diagnostic skin testing is generally considered safe.

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, nursing, or have chronic kidney or liver issues.

Histamine Phosphate is a direct-acting H1 and H2 receptor agonist.

• H1 Receptor Activation: This is the primary mechanism for diagnostic skin testing. Activation of H1 receptors on vascular endothelial cells triggers the release of nitric oxide and prostacyclin, leading to vasodilation. It also causes the contraction of endothelial cells, creating gaps that allow fluid to leak into the extravascular space, forming a wheal. Furthermore, histamine stimulates sensory nerve endings (C-fibers), causing the 'flare' (redness) through an axonal reflex and producing the sensation of itching.
• H2 Receptor Activation: In the stomach, histamine binds to H2 receptors on the basolateral membrane of parietal cells. This activates adenylate cyclase, increasing intracellular cAMP, which in turn activates the proton pump (H+/K+ ATPase) to secrete hydrochloric acid into the stomach lumen.

• Onset of Action: For skin testing, the onset is almost immediate. The wheal begins to form within 3-5 minutes.
• Peak Effect: The maximum size of the wheal and flare reaction typically occurs at 15 minutes.
• Duration of Effect: The local reaction usually subsides within 30 to 60 minutes. Systemic effects, if they occur, are generally very brief (5-10 minutes) due to rapid enzymatic degradation.

| Parameter | Value |

|---|---|

| Bioavailability | High (local/subcutaneous); Low (oral due to first-pass) |

| Protein Binding | Minimal (<10%) |

| Half-life | < 5 minutes (plasma) |

| Tmax | 15 minutes (local skin reaction) |

| Metabolism | HNMT (primary) and Diamine Oxidase (DAO) |

| Excretion | Renal (>90% as metabolites) |

• Molecular Formula: C5H9N3 · 2H3PO4 (as Histamine Phosphate)
• Molecular Weight: 307.14 g/mol
• Solubility: Freely soluble in water; insoluble in ether.
• Structure: Consists of an imidazole ring attached to an ethylamine chain, with two phosphate groups in the salt form. It is a clear, colorless, odorless solution.

Histamine Phosphate is classified as an Autacoid and a Diagnostic Biological. In the Electronic Orange Book, it is often grouped under Allergenic Extracts because of its role as a standardized control for those products. It is the 'gold standard' against which the potency of other allergenic extracts and the efficacy of antihistamine medications are measured.